Effects of Common Polymorphism rs11614913 in Hsa-miR-196a2 on Lung Cancer Risk

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Yuan, Zhengrong ^a   Zeng, Xu ^a   Yang, Dan ^a   Wang, Weilu ^a,c   Liu, Zhihua ^a,b  

^a INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

^b NANJING FORESTRY UNIVERSITY   (China)

^c BEIJING CITY UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HSA MICRORNA 196A2; MICRORNA; UNCLASSIFIED DRUG;

ARTICLE; ASIAN; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNICITY; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HOMOZYGOTE; HUMANS; LUNG NEOPLASMS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS;

EID: 84876084238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061047     Document Type: Article

References (73)

1. Parkin DM, Bray F, Ferlay J, Pisani P, (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156.
2. Biaoxue R, Shuanying Y, Wei L, Wei Z, Zongjuan M, (2012) Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer. World J Surg Oncol 10: 170.
3. Sekido Y, Fong KM, Minna JD, (2003) Molecular genetics of lung cancer. Annu Rev Med 54: 73-87.
4. Meyerson M, Carbone D, (2005) Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy. J Clin Oncol 23: 3219-3226.
5. Granville CA, Dennis PA, (2005) An overview of lung cancer genomics and proteomics. Am J Respir Cell Mol Biol 32: 169-176.
6. Minna JD, Roth JA, Gazdar AF, (2002) Focus on lung cancer. Cancer Cell 1: 49-52.
7. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, et al. (2006) Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
8. Tian T, Shu Y, Chen J, Hu Z, Xu L, et al. (2009) A functional genetic variant in microRNA-196a2 is associated with increased susceptibility of lung cancer in Chinese. Cancer Epidemiol Biomarkers Prev 18: 1183-1187.
9. Hu Z, Chen J, Tian T, Zhou X, Gu H, et al. (2008) Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest 118: 2600-2608.
10. Kim MJ, Yoo SS, Choi YY, Park JY, (2010) A functional polymorphism in the pre-microRNA-196a2 and the risk of lung cancer in a Korean population. Lung Cancer 69: 127-129.
11. Hong YS, Kang HJ, Kwak JY, Park BL, You CH, et al. (2011) Association between microRNA196a2 rs11614913 genotypes and the risk of non-small cell lung cancer in Korean population. J Prev Med Public Health 44: 125-130.
12. Vinci S, Gelmini S, Pratesi N, Conti S, Malentacchi F, et al. (2011) Genetic variants in miR-146a, miR-149, miR-196a2, miR-499 and their influence on relative expression in lung cancers. Clin Chem Lab Med 49: 2073-2080.
13. Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, et al. (2012) The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer. J Thorac Cardiovasc Surg 144(4): 794-807.
14. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
15. Xu W, Xu J, Liu S, Chen B, Wang X, et al. (2011) Effects of common polymorphisms rs11614913 in miR-196a2 and rs2910164 in miR-146a on cancer susceptibility: a meta-analysis. PLoS One 6: e20471.
16. Xu P, Guo M, Hay BA, (2004) MicroRNAs and the regulation of cell death. Trends in genetics: TIG 20: 617-624.
17. Bartel DP, Chen CZ, (2004) Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 5: 396-400.
18. Landi D, Gemignani F, Naccarati A, Pardini B, Vodicka P, et al. (2008) Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer. Carcinogenesis 29: 579-584.
19. Calin GA, Croce CM, (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866.
20. Chen K, Song F, Calin GA, Wei Q, Hao X, et al. (2008) Polymorphisms in microRNA targets: a gold mine for molecular epidemiology. Carcinogenesis 29: 1306-1311.
21. Chu H, Wang M, Shi D, Ma L, Zhang Z, et al. (2011) Hsa-miR-196a2 Rs11614913 polymorphism contributes to cancer susceptibility: evidence from 15 case-control studies. PLoS One 6: e18108.
22. Wang Z, Cao Y, Jiang C, Yang G, Wu J, et al. (2012) Lack of Association of Two Common Polymorphisms rs2910164 and rs11614913 with Susceptibility to Hepatocellular Carcinoma: A Meta-Analysis. PLoS One 7: e40039.
23. Saunders MA, Liang H, Li WH, (2007) Human polymorphism at microRNAs and microRNA target sites. Proc Natl Acad Sci U S A 104: 3300-3305.
24. Hu Z, Liang J, Wang Z, Tian T, Zhou X, et al. (2009) Common genetic variants in pre-microRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 30: 79-84.
25. Hoffman AE, Zheng T, Yi C, Leaderer D, Weidhaas J, et al. (2009) microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 69: 5970-5977.
26. Catucci I, Yang R, Verderio P, Pizzamiglio S, Heesen L, et al. (2010) Evaluation of SNPs in miR-146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 31: E1052-1057.
27. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, et al. (2010) Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 55: 2288-2293.
28. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, et al. (2010) Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter 15: 524-531.
29. Li XD, Li ZG, Song XX, Liu CF, (2010) A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42: 669-673.
30. Qi P, Dou TH, Geng L, Zhou FG, Gu X, et al. (2010) Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection. Hum Immunol 71: 621-626.
31. Akkiz H, Bayram S, Bekar A, Akgollu E, Ulger Y, (2011) A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a case-control study. J Viral Hepat 18: e399-407.
32. Srivastava K, Srivastava A, Mittal B, (2010) Common genetic variants in pre-microRNAs and risk of gallbladder cancer in North Indian population. J Hum Genet 55: 495-499.
33. George GP, Gangwar R, Mandal RK, Sankhwar SN, Mittal RD, (2011) Genetic variation in microRNA genes and prostate cancer risk in North Indian population. Mol Biol Rep 38: 1609-1615.
34. Ye Y, Wang KK, Gu J, Yang H, Lin J, et al. (2008) Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila) 1: 460-469.
35. Wang K, Guo H, Hu H, Xiong G, Guan X, et al. (2010) A functional variation in pre-microRNA-196a is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers 15: 614-618.
36. Dou T, Wu Q, Chen X, Ribas J, Ni X, et al. (2010) A polymorphism of microRNA196a genome region was associated with decreased risk of glioma in Chinese population. J Cancer Res Clin Oncol 136: 1853-1859.
37. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, et al. (2010) Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer 116: 4753-4760.
38. Guo J, Jin M, Zhang M, Chen K, (2012) A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One 7: e30585.
39. Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, et al. (2011) miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine 56: 589-592.
40. Tian T, Xu Y, Dai J, Wu J, Shen H, et al. (2010) Functional polymorphisms in two pre-microRNAs and cancer risk: a meta-analysis. Int J Mol Epidemiol Genet 1: 358-366.
41. Wang F, Ma YL, Zhang P, Yang JJ, Chen HQ, et al. (2012) A genetic variant in microRNA-196a2 is associated with increased cancer risk: a meta-analysis. Mol Biol Rep 39: 269-275.
42. Gao LB, Bai P, Pan XM, Jia J, Li LJ, et al. (2011) The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. Breast Cancer Res Treat 125: 571-574.
43. He B, Pan Y, Cho WC, Xu Y, Gu L, et al. (2012) The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One 7: e49032.
44. Wang J, Wang Q, Liu H, Shao N, Tan B, et al. (2012) The association of miR-146a rs2910164 and miR-196a2 rs11614913 polymorphisms with cancer risk: a meta-analysis of 32 studies. Mutagenesis 27: 779-788.
45. Wang P, Xie S, Cui A, Zhang Y, Jiang B, (2012) miR-196a2 polymorphisms and susceptibility to cancer: A meta-analysis involving 24,697 subjects. Exp Ther Med 3: 324-330.
46. Moher D, Liberati A, Tetzlaff J, Altman DG, (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6: e1000097.
47. Cochran WG, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
48. Higgins JP, Thompson SG, (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21: 1539-1558.
49. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
50. Lau J, Ioannidis JP, Schmid CH, (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127: 820-826.
51. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
52. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
53. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
54. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
55. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
56. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
57. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
58. Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T, (2007) Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet 39: 673-677.
59. Kwak PB, Iwasaki S, Tomari Y, (2010) The microRNA pathway and cancer. Cancer Sci 101: 2309-2315.
60. Gregory RI, Shiekhattar R, (2005) MicroRNA biogenesis and cancer. Cancer Res 65: 3509-3512.
61. Sassen S, Miska EA, Caldas C, (2008) MicroRNA: implications for cancer. Virchows Arch 452: 1-10.
62. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402.
63. Hamada J, Omatsu T, Okada F, Furuuchi K, Okubo Y, et al. (2001) Overexpression of homeobox gene HOXD3 induces coordinate expression of metastasis-related genes in human lung cancer cells. Int J Cancer 93: 516-525.
64. Volpe MV, Pham L, Lessin M, Ralston SJ, Bhan I, et al. (2003) Expression of Hoxb-5 during human lung development and in congenital lung malformations. Birth Defects Res A Clin Mol Teratol 67: 550-556.
65. Calvo R, West J, Franklin W, Erickson P, Bemis L, et al. (2000) Altered HOX and WNT7A expression in human lung cancer. Proc Natl Acad Sci U S A 97: 12776-12781.
66. Yekta S, Shih IH, Bartel DP, (2004) MicroRNA-directed cleavage of HOXB8 mRNA. Science 304: 594-596.
67. Liu ZH, Yang D, Xie P, Ren GM, Sun GB, et al. (2012) MiR-106b and MiR-15b Modulate Apoptosis and Angiogenesis in Myocardial Infarction. Cell Physiol and Biochem 29: 851-862.
68. Liu ZH, Chu GY, (2013) Chronobiology in mammalian health. Mol Biol Rep 40: 2491-2501.
69. Ren GM, Liu ZH, (2013) NetCAD: a network analysis tool for coronary artery disease associated PPI network. Bioinformatics 29(2): 279-280.
70. Hu RF, Zeng X, Gao WW, Wang Q, Liu ZH, (2013) HRAS: a webserver for early warning of human health risk brought by aflatoxin. Mol Biol Rep 40(2): 1181-1187.
71. Liu ZH, Chen SL, (2010) ER regulates an evolutionarily conserved apoptosis pathway. Biochem Biophys Res Commun 400(1): 34-38.
72. Yang D, Xie P, Liu ZH, (2012) Ischemia/reperfusion-induced MKP-3 impairs endothelial NO formation via inactivation of ERK1/2 pathway. PLoS ONE 7(7): e42076.
73. Yuan ZR, Chu GY, Dan Y, Li J, Zhang LP, et al. (2012) BRCA1: a new candidate gene for bovine mastitis and its association analysis between single nucleotide polymorphisms and milk somatic cell score. Mol Biol Rep 39(6): 6625-6631.